$BMY Headlines Bristol-Myers guidance tops estimates

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$BMY Headlines

Bristol-Myers guidance tops estimates 7:06 a.m. Jan. 28, 2016 - MarketWatch.com
Apple, Amazon headline crucial week for Wall Street quarterly results 9:30 a.m. Jan. 23, 2016 - Wallace Witkowski
10 biotech stocks to buy at ‘silly’ cheap prices 10:10 a.m. Jan. 16, 2016 - Michael Brush
Shire agrees to buy Baxalta for $32 billion 8:49 a.m. Jan. 11, 2016 - MarketWatch.com
GlaxoSmithKline buys Bristol-Myers HIV assets 4:33 a.m. Dec. 18, 2015 - MarketWatch.com
GlaxoSmithKline to buy Bristol-Myers's HIV assets 3:21 a.m. Dec. 18, 2015 - MarketWatch.com
Samsung's bet on biotech is test for heir apparent 5:37 p.m. Dec. 17, 2015 - MarketWatch.com
5 stocks to watch 12:18 p.m. Dec. 16, 2015 - The Trading Deck
Charting the S&P 500’s impending golden cross 11:05 a.m. Dec. 9, 2015 - Michael Ashbaugh
S&P 500 will creep up to 2,200 in 2016, J.P. Morgan says 7:01 a.m. Dec. 7, 2015 - Sara Sjolin
Bristol-Myers Squibb upgraded to buy from neutral at Guggenheim 12:04 p.m. Dec. 2, 2015 - Tomi Kilgore
Merck, J&J and Lilly shares climb after upgrades at Barclays 10:14 a.m. Dec. 1, 2015 - Tomi Kilgore
Bristol-Myers Squibb stock price target raised to $70 from $55 at Barclays 9:44 a.m. Dec. 1, 2015 - Tomi Kilgore
Bristol-Myers to buy Cardioxyl Pharmaceuticals 8:11 a.m. Nov. 2, 2015 - Ciara Linnane
Merck eyes acquisitions amid slump in biotech 12:12 p.m. Oct. 27, 2015 - MarketWatch.com
Merck profit more than doubles, raises outlook 7:06 a.m. Oct. 27, 2015 - MarketWatch.com
Bristol-Myers shares up 3.6% in premarket trade 6:20 a.m. Oct. 27, 2015 - Ciara Linnane
Bristol-Myers revenue buoyed by cancer drug 6:02 a.m. Oct. 27, 2015 - MarketWatch.com
Apple clashes with energy to save earnings season 7:00 a.m. Oct. 25, 2015 - Wallace Witkowski
Five Prime's stock rockets 57% premarket after licensing deal with Bristol-Myers 7:19 a.m. Oct. 15, 2015 - Tomi Kilgore


Healthcare ratings roundup 50 min ago - Seeking Alpha
Bristol-Myers Squibb (BMY) Earnings Report: Q4 2015 Conference Call Transcript 7:45 a.m. Today - TheStreet.com
Bristol-Myers Squibb's (BMY) CEO Giovanni Caforio on Q4 2015 Results - Earnings Call Transcript 4:40 p.m. Jan. 28, 2016 - Seeking Alpha
'The Market Doesn't Know Where It's Headed' 4:02 p.m. Jan. 28, 2016 - TheStreet.com
Stocks Back Near Highs in Unsettled Session 2:23 p.m. Jan. 28, 2016 - TheStreet.com
Bristol-Myers Revenue Rises 1% 1:12 p.m. Jan. 28, 2016 - The Wall Street Journal Interactive Edition
Expanded uses of Bristol-Myers Squibb's HCV med Daklinza cleared in Europe 12:59 p.m. Jan. 28, 2016 - Seeking Alpha
Vetr Top Raters Upgrade Bristol-Myers Squibb, Over 80% Bullish 11:20 a.m. Jan. 28, 2016 - benzinga.com
Stocks Back to Positive as Energy Trumps Health Care 11:16 a.m. Jan. 28, 2016 - TheStreet.com
Trade-Ideas: Bristol-Myers Squibb Company (BMY) Is Today's Unusual Social Activity Stock 10:53 a.m. Jan. 28, 2016 - TheStreet.com
Bristol-Myers Beats on Q4 Earnings, Provides 2016 Guidance 10:12 a.m. Jan. 28, 2016 - Zacks.com
Bristol-Myers' Opdivo successful in late-stage study in head and neck cancer 9:43 a.m. Jan. 28, 2016 - Seeking Alpha
Bristol-Myers (BMY) Beats on Q4 Earnings and Revenues 8:13 a.m. Jan. 28, 2016 - Zacks.com
Short Sellers Become More Selective on Major Pharma 7:59 a.m. Jan. 28, 2016 - 247WallSt.com
Bristol-Myers Q4 product sales up 19%; non-GAAP EPS down 17%; net loss of $138M 7:25 a.m. Jan. 28, 2016 - Seeking Alpha
Bristol Myers Ticks Higher Following Q4 Beat, Encouraging Guidance 6:54 a.m. Jan. 28, 2016 - benzinga.com
Trade-Ideas: Bristol-Myers Squibb Company (BMY) Is Today's Post-Market Leader Stock 5:55 p.m. Jan. 27, 2016 - TheStreet.com
Notable earnings before Thursday’s open 5:30 p.m. Jan. 27, 2016 - Seeking Alpha
Bristol-Myers Squibb (BMY) Closed Down as Analysts Expect Earnings Decline 4:06 p.m. Jan. 27, 2016 - TheStreet.com
Lilly’s Valuation Multiples Have Followed the Industry’s Trend 1:20 p.m. Jan. 22, 2016 - MarketRealist.com


Bristol-Myers Squibb and AbbVie Receive Positive CHMP Opinion forInvestigational Antibody, Empliciti (elotuzumab), for the Treatment of Multiple Myeloma in Patients Who Have Received at Least One Prior Therapy 7:48 a.m. Today - BusinessWire - BZX
European Commission Approves Daklinza (daclatasvir) for the Treatment of Genotype 1, 3 and 4 Chronic Hepatitis C Patients with HIV Coinfection, Advanced Cirrhosis and Post-liver Transplant Recurrence of HCV 12:41 p.m. Jan. 28, 2016 - BusinessWire - BZX
CheckMate -141, a Pivotal Phase 3 Opdivo (nivolumab) Head and Neck Cancer Trial, Stopped Early 6:59 a.m. Jan. 28, 2016 - BusinessWire - BZX
Tarveda Therapeutics Appoints Oncology Drug Development Leader Leila Alland, M.D., as Chief Medical Officer 7:02 a.m. Jan. 27, 2016 - BusinessWire - BZX
Dako, an Agilent Technologies Company, Announces Expanded FDA Approval of Complementary Diagnostic Test to Include Melanoma 8:00 a.m. Jan. 25, 2016 - BusinessWire - BZX
REPEAT/ Bristol-Myers Squibb’s Opdivo (nivolumab) + Yervoy (ipilimumab) Regimen Receives Expanded FDA Approval in Unresectable or Metastatic Melanoma Across BRAF Status1 6:59 a.m. Jan. 25, 2016 - BusinessWire - BZX
Bristol-Myers Squibb’s Opdivo (nivolumab) + Yervoy (ipilimumab) Regimen Receives Expanded FDA Approval in Unresectable or Metastatic Melanoma Across BRAF Status1 6:36 p.m. Jan. 23, 2016 - BusinessWire - BZX
Glioblastoma Multiforme Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022 4:52 p.m. Jan. 20, 2016 - PR Newswire - PRF
Cancer Immunotherapy: Payer Insight 3:41 p.m. Jan. 20, 2016 - PR Newswire - PRF
CytomX Announces Third Target Selection by Bristol-Myers Squibb, Triggering Milestone 8:01 a.m. Jan. 20, 2016 - GlobeNewswire
MOLOGEN AG: First combination trial with MGN1703and a checkpoint inhibitor in collaboration with MD Anderson 4:09 a.m. Jan. 19, 2016 - BusinessWire - BZX
SomaLogic Completes Agreement With Bristol-Myers Squibb for Expanded Access to SOMAmer(R) Reagents 8:02 a.m. Jan. 11, 2016 - Marketwired
Dual Therapeutics Announces Oncology Strategic Collaboration With Bristol-Myers Squibb 8:00 a.m. Jan. 8, 2016 - Marketwired
Antibacterial Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 3:39 p.m. Jan. 7, 2016 - PR Newswire - PRF
Insights on Immuno-Oncology Drug Development and the Field’s True Potential 6:00 a.m. Jan. 6, 2016 - BusinessWire - BZX
Pharmacovigilance Market: Global Industry Analysis and Opportunity Assessment, 2015 - 2020 4:39 p.m. Jan. 5, 2016 - PR Newswire - PRF
Bristol-Myers Squibb to Present at J.P. Morgan Healthcare Conference 10:00 a.m. Jan. 5, 2016 - BusinessWire - BZX
Fitch Affirms Bristol-Myers Squibb's IDR at 'A-'; Outlook Stable 2:17 p.m. Dec. 23, 2015 - BusinessWire - BZX
Seattle Genetics and Bristol-Myers Squibb Announce Initiation of Phase 1/2 Clinical Trial of ADCETRIS® (Brentuximab Vedotin)in Combination with Opdivo® (Nivolumab) in Relapsed or Refractory Non-Hodgkin Lymphoma 8:00 a.m. Dec. 23, 2015 - BusinessWire - BZX
Global Psoriatic Arthritis Market 2015-2019 4:47 p.m. Dec. 22, 2015 - PR Newswire - PRF

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Newegg’s GIGABYTE Event Is Brand Work, Not a Catalyst

Updated Category News Views 530

A 2,300-square-foot room can tell a retailer plenty about its tribe. On November 21, Newegg is turning its Diamond Bar Gamer Zone into the home base for GIGABYTE’s AORUS VS40 celebration, a free five-hour event marking the hardware maker’s 40th anniversary. There will be 1v1 VALORANT and League of Legends contests, demo stations, raffles, anniversary merchandise, food...

Continue Reading
UAE Ties Diplomacy, Media and AI Into a Shared Signal

Updated Category News Views 128

Influence is getting harder to measure, and easier to squander, which is why the message from Ajman deserves more than a polite nod. At the 2026 Ajman Media Forum, THE SIGNAL, Foreign Affairs Undersecretary Omar Obaid Alhesan Alshamsi made the UAE’s position plain: diplomacy and media are no longer separate lanes. Both operate on words, context, trust and the difficult...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 731

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 270

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 534

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
Cardiovalve's Three-Year Data Clears a Crucial EU Hurdle

Updated Category News Views 98

A failing tricuspid valve is not a spreadsheet problem, and that matters before anybody gets carried away with a glossy conference presentation. Venus Medtech's Cardiovalve unit has reported results from TARGET in a population that was old, sick and largely out of good surgical options. That is precisely where a less invasive replacement therapy has to prove it can do...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 332

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 398

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
FASTEN Data Offers an Early Look at Ladera Closure

Updated Category News Views 137

Femoral access may be the unglamorous part of a valve procedure, but it is where an otherwise tidy case can turn ugly in a hurry. That makes Ladera Medical's full FASTEN data worth a careful look. The company reported results in 55 patients undergoing transfemoral TAVR/TAVI, and the numbers presented at London Valves 2026 suggest its large-bore closure system may address...

Continue Reading
Global Child Tests Purpose Travel's Expanding Media Reach

Updated Category News Views 45

Celebrity travel programming usually melts into the wallpaper, but Global Child is trying to make the scenery answer for itself. Its new season of Global Child “Travel & Purpose” puts Andrea Bocelli in Tuscany, Isabela Merced in Peru and John Malkovich in Croatia, while tying each destination to a broader local-good mission. That is a more thoughtful pitch than...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the Innovative CORDStrom™ Platform by INmune Bio

Updated Category News Views 200

Introduction to CORDStrom™ and Its Significance INmune Bio, Inc. (NASDAQ: INMB), a pioneer in the field of inflammation and immunology therapies, has recently sparked significant interest in the medical community. Their intriguing CORDStrom™ platform signifies a promising advance in mesenchymal stromal cell (MSC) therapies, aiming to address various health conditions...

Continue Reading
Brooklyn Law School Enhances Scholarship Support for Veterans

Updated Category News Views 156

Brooklyn Law School Expands Support for Veteran Students Brooklyn Law School has taken significant steps to demonstrate its commitment to veterans by increasing scholarship support, ensuring they receive the assistance they need to excel in their legal education. This initiative reflects a profound recognition of the sacrifices made by our armed forces members and aims to...

Continue Reading
Unlocking Creativity with the New vivo X200 FE Smartphone

Updated Category News Views 441

Introducing the vivo X200 FE: Ideal for the Innovative Generation Vivo proudly announces the launch of the X200 FE, a cutting-edge smartphone designed with the vibrant essence of the new generation in mind. This model combines playful aesthetics with dependable functionality, delivering an exceptional user experience. With its striking color-blocking design and advanced...

Continue Reading
Exploring Market Sentiment Towards Westinghouse Air Brake Tech

Updated Category News Views 201

Current Sentiment Around Westinghouse Air Brake Technologies Corp Westinghouse Air Brake Technologies Corp (NYSE: WAB) is a prominent player in the transportation industry, particularly known for its innovation in braking systems and other technology. Recently, it has come to light that the short interest as a percentage of its float has decreased significantly, by...

Continue Reading
Asante Gold Highlights Shareholder Meeting Information and Voting

Updated Category News Views 165

Key Information about Asante Gold's Upcoming Shareholder Meeting Your participation is crucial, regardless of how many shares you own in Asante Gold. The Company’s Board of Directors strongly advises all shareholders to vote for all resolutions presented. Proxy Materials Available Online Asante Gold Corporation (TSXV: ASE | GSE: ASG | OTCQX: ASGOF) has announced that...

Continue Reading